OUR PRINCIPAL INVESTIGATOR
Dr. Shahnaz Fatteh, MD
Dr. Shahnaz Fatteh is a highly accomplished physician and clinical researcher with extensive expertise in Allergy, Immunology, and Internal Medicine, bringing a strong scientific and patient-centered perspective to Medilife Research.
With a distinguished career spanning academic medicine, hospital-based practice, and clinical research, Dr. Fatteh has played a key role in advancing innovative therapies, particularly in immunology-driven and inflammatory conditions. Her background allows Medilife Research to strategically support complex clinical trials that require deep understanding of immune mechanisms, safety profiling, and patient diversity.
At Medilife Research, Dr. Fatteh provides medical leadership and scientific oversight for clinical trials, ensuring protocol integrity, subject safety, and high-quality data generation. Her experience and professional network within the immunology, allergy, and internal medicine communities strengthen Medilife's ability to attract and successfully conduct studies in vaccines, immunomodulatory therapies, and chronic immune-mediated diseases.
Dr. Fatteh's academic and clinical foundation, combined with her ongoing involvement in research, reflects a strong commitment to medical innovation, translational science, and improving patient outcomes through evidence-based medicine.
Clinical Research Experience
- Vaccine and Immunology-Focused Clinical Trials
- Immunomodulatory and Inflammatory Disease Studies
- Safety and Efficacy Trials in Adult and Elderly Populations
- Safety and Efficacy Study of ALLOSTIM Universal Anti-Viral
- Multicenter Clinical Research Collaboration
OUR SECONDARY INVESTIGATOR
Dr. Hector A. Fabregas Cherenek
Dr. Fabregas has held prestigious leadership roles, including Chief of the Department of Internal Medicine at Memorial Hospital Miramar and Vice-Chairman of the Broward Guardian Accountable Care Organization. His extensive involvement in clinical trials, ranging from novel vaccines to treatments for pulmonary arterial hypertension, demonstrates his dedication to medical progress.
At Medilife Research, Dr. Fabregas leads clinical trials that contribute to the development of innovative treatments and therapies.
His medical journey began at the Higher Institute of Medical Sciences of Havana, Cuba, where he earned his Doctor of Medicine degree. Furthering his expertise, he specialized in Urology and became Board Certified in Family Medicine, also achieving Board Eligibility in Geriatric Medicine. His dedication to continued learning and research has significantly contributed to advancements in patient care.
Clinical Trial Experience
- Phase 3 Multicenter Study for Pulmonary Arterial Hypertension Treatment
- Phase 1/2 Safety and Immunogenicity Study of SARS-CoV2 Vaccine
- Phase 1/2 Study Evaluating a Novel Adjuvant Vaccine in Healthy Adults
- Safety and Efficacy Study of ALLOSTIM Universal Anti-Viral
- Immunomodulatory Vaccine in Elderly Adults.